Core Viewpoint - EnviroGold Global Limited has appointed Karina Nott as Chief Financial Officer to enhance its executive leadership and support the commercial deployment of its proprietary NVRO Process™ and achieve key commercialization milestones and revenue targets [1][2]. Leadership Appointment - Ms. Nott's appointment is effective March 23, 2026, and is expected to strengthen the company's leadership as it develops a scalable, multi-jurisdictional project pipeline [2]. - The previous Interim Chief Financial Officer, Peter Nguyen, has resigned but will assist with the transition and the 2025 audit [5]. Ms. Nott's Experience - Ms. Nott has over 20 years of international experience in capital markets, financial strategy, and scaling high-growth technology companies [3]. - She has a strong track record in capital raising, having supported significant funding initiatives across Series B and Series C financings, as well as structured transactions [3][4]. - Her most recent role was as VP of Finance at a global satellite-enabled IoT company, where she contributed to capital strategy and international expansion [4]. Company Strategy and Technology - EnviroGold Global focuses on clean technology that recovers high-value metals from sulfidic mine waste and tailings using its NVRO Process™ [6]. - The company's approach aims to provide scalable, lower-impact metal recovery solutions that align with global ESG frameworks and critical-minerals strategies [6].

Core Viewpoint - EnviroGold Global Limited has successfully completed Phase 2 of its test work program on tailings from Hecla Mining Company's Greens Creek Mine, demonstrating the potential for high recovery rates of precious metals using its proprietary NVRO Process™ [1][2][5]. Group 1: Project Development - The completion of Phases 1 and 2 confirms the technical suitability of the Greens Creek tailings for the NVRO Process™, achieving recovery rates of 98.07% for silver and 99.46% for gold [2]. - A bulk sample from Greens Creek is being shipped to EnviroGold's facility in West Australia for further pilot plant optimization and demonstration-scale processing [3]. - Phases 3 and 4 are designed to optimize process conditions, validate product quality, evaluate waste stream characteristics, and generate engineering data for techno-economic modeling [4]. Group 2: Environmental and Commercial Potential - The project aims to recover silver, gold, base metals, and critical minerals from sulfidic tailings while reducing long-term environmental liabilities associated with legacy mine waste [5]. - The NVRO Process™ has the potential to unlock significant metal production from the Greens Creek tailings, which were not recovered during the mine's 35-year operational history [5]. - The company emphasizes the alignment of its operations with global ESG frameworks and critical minerals strategies, providing scalable and lower-impact metal recovery solutions [6].

Group 1 - EnviroGold Global Limited's common shares will be delisted from the Canadian Securities Exchange (CSE) at market close on February 3, 2026 [1][2] - The issuer will continue to trade on the TSX Venture Exchange [1][2] - The stock symbol for EnviroGold Global Limited is NVRO [3]

Core Viewpoint - EnviroGold Global Limited is hosting a live investor webinar to discuss the opportunity of recovering precious and critical metals from existing above-ground assets using its proprietary NVRO Process™, which aligns with global supply-security objectives and offers improved economic and environmental outcomes [1][3]. Company Strategy and Objectives - The webinar will outline the company's strategy, path to revenue and earnings, technology buildout, strategic partnerships, and key objectives for 2026 [2]. - The presentation aims to provide a clear, non-technical understanding of EnviroGold's opportunity and long-term value creation pathway [9]. Market Context and Opportunities - Rising global demand for gold, silver, copper, and critical minerals is driven by electrification, infrastructure investment, defense requirements, and supply chain resilience [4]. - New mine development is constrained by lengthy permitting timelines, capital intensity, and environmental considerations, making tailings a significant, under-recognized source of metal supply [4][5]. NVRO Process™ and Environmental Impact - The NVRO Process™ allows mining companies to recover additional precious and critical metals from existing tailings, improving asset returns while reducing long-term environmental liabilities [6]. - This approach, termed "Metals Without Mining," enhances and complements existing mining operations [6]. Regulatory Alignment and Competitive Advantage - Governments are prioritizing secure, domestic sources of precious and critical metals, with U.S. critical minerals mandates recognizing recycling and secondary recovery as essential for supply-chain security [7]. - Recovery using the NVRO Process™ can be achieved faster and at lower costs than developing new mines, while also delivering improved environmental outcomes [8]. Webinar Focus Areas - The webinar will cover the scale of the global above-ground metals opportunity, economic and environmental advantages of tailings recovery, critical-minerals policy support, and the NVRO Process™ [10]. - It will also discuss EnviroGold's capital-light, licensing-led business model and key milestones expected in 2026 [10].

Core Viewpoint - EnviroGold Global Limited has successfully converted and retired approximately $10.2 million in debt, marking a significant milestone as it moves towards the commercialization of its proprietary NVRO Process™ [1][3]. Debt Conversion and Financial Position - The company fully converted $4,119,000 in Convertible Promissory Notes into 68,650,446 shares at $0.06 per share, with additional shares issued for interest and costs [2]. - The retirement of all convertible and promissory liabilities results in a clean balance sheet, positioning the company for future growth [3]. Insider Transactions - Two insiders converted a total of $100,000 in principal of the Notes into common shares, which is classified as a related-party transaction under MI 61-101 [3]. - The company is relying on exemptions from formal valuation and minority shareholder approval requirements due to the fair-market value of the securities issued not exceeding C$2,500,000 [3]. Corporate Matters - The company will issue 1,851,852 common shares at a deemed price of $0.135 per share as partial payment for an engagement fee to Cantor Fitzgerald Canada Corporation [4]. - An aggregate of 850,000 common shares will be issued to the estate of former director Harold Wolkin in recognition of his services [5]. Equity Awards and Incentives - The company issued conversion premiums totaling 1,271,405 shares at a deemed price of $0.15 per share in connection with the Note conversions [6]. - On November 6, 2025, the company granted 5,637,501 restricted share units (RSUs), 18,500,000 performance share units (PSUs), and 257,000 stock options to directors and officers as incentive compensation [8]. Performance Conditions - The Options are exercisable at $0.14 per share for five years and vested upon issuance, while RSUs will vest in tranches according to individual agreements [9]. - PSUs are tied to performance-based milestones, including revenue thresholds and volume-weighted average price (VWAP) targets [10]. Company Overview - EnviroGold Global Limited focuses on transforming the mining industry by recovering high-value metals from mine waste and tailings, utilizing its proprietary NVRO Process™ for efficient, low-carbon extraction [14].

Core Viewpoint - Nevro Corp. is under investigation for potential data privacy violations following a network breach that may have compromised sensitive personal information of individuals [1][3][5]. Company Overview - Nevro Corp. is a medical device company based in Redwood City, California, recognized for its HFX spinal cord stimulation (SCS) platform [2]. Incident Details - On or around December 1, 2024, Nevro detected suspicious activity on its network, leading to an investigation that revealed unauthorized access to sensitive personal information between November 21, 2024, and December 1, 2024 [3]. Compromised Information - The types of personal information that may have been accessed include names, Social Security numbers, driver's license numbers, financial information (account numbers or credit/debit card numbers), medical information, and health insurance information [4][8]. Legal Action - Edelson Lechtzin LLP is investigating a class action lawsuit to seek legal remedies for individuals whose sensitive personal data may have been compromised due to the data breach at Nevro [5].

Core Points - Nevro Corp. has been investigated for a data breach, filing a notice with the Attorney General of Texas on April 3, 2025 [1] - Approximately 6,381 Texans have been affected by the data breach [1] - The potentially exposed information includes full names, Social Security numbers, driver's license numbers, financial information, medical information, health insurance information, and other sensitive information [2] Company Overview - Nevro Corp. is a medical device company headquartered in Redwood City, California [1]

Company Overview - Nevro (NVRO) shares have increased by approximately 0.9% since the last earnings report, outperforming the S&P 500 [1] - The most recent earnings report is essential for understanding the key drivers of the company's performance [1] Earnings Estimates - Estimates for Nevro have trended upward over the past month, indicating positive sentiment among analysts [2][4] - The current Zacks Rank for Nevro is 3 (Hold), suggesting an expectation of in-line returns in the coming months [4] VGM Scores - Nevro has a Growth Score of B, a Momentum Score of F, and a Value Score of C, resulting in an aggregate VGM Score of C, placing it in the middle 20% for investment strategies [3] Industry Performance - Nevro operates within the Zacks Medical - Instruments industry, where Fresenius (FMS) has seen a 4.3% increase in share price over the past month [5] - Fresenius reported revenues of $5.42 billion for the last quarter, reflecting a year-over-year growth of 1%, with an EPS of $0.48 compared to $0.47 a year ago [5] - Fresenius is projected to earn $0.45 per share for the current quarter, representing a year-over-year increase of 25%, with a Zacks Consensus Estimate revision of 3.5% over the last 30 days [6] - Fresenius holds a Zacks Rank of 1 (Strong Buy) and has a VGM Score of B, indicating strong performance expectations [6]

Core Insights - Nevro Corp. reported a wider loss per share of 64 cents in Q4 2024 compared to a loss of 15 cents in the same quarter last year, while the Zacks Consensus Estimate was a loss of 79 cents [1] - The company's worldwide revenues for Q4 2024 were $105.5 million, reflecting a decline of 9.1% year over year, but exceeding the Zacks Consensus Estimate by 1.5% [2] - Nevro's gross profit decreased by 19.1% year over year to $65.1 million, resulting in a gross margin of 62.5%, down from 70.1% in the prior year [8] Revenue Details - International revenues were $14.4 million, down 3.8% year over year, while U.S. revenues totaled $91.4 million, down 9.9% year over year [3] - Total U.S. permanent implant procedures declined by 7% year over year, and U.S. trial procedures decreased by 14.2% year over year [3] Product Developments - Nevro launched the full market release of HFX iQ with HFX AdaptivAI, a personalized pain management platform, in the U.S. and select European countries [4] - Key publications highlighted the effectiveness of Nevro's 10 kHz high-frequency SCS therapy in providing significant pain relief and other health benefits [5][6] Acquisition Announcement - Nevro entered into a definitive agreement with Globus Medical for an all-cash acquisition valued at approximately $250 million, or $5.85 per share, expected to close in Q2 2025 [7] Financial Position - At the end of Q4 2024, Nevro had cash and cash equivalents of $292.5 million, an increase from $277 million at the end of Q3 2024, while long-term debt rose to $187.7 million from $184.4 million [12] Guidance and Market Outlook - Nevro has not issued full-year 2025 guidance due to the pending acquisition [13] - Despite challenges in the U.S. SCS market, Nevro is positioned for growth with new product launches and diversification into the SI joint fusion market [15]

Company Performance - Nevro reported a quarterly loss of $0.64 per share, better than the Zacks Consensus Estimate of a loss of $0.79, and compared to a loss of $0.15 per share a year ago, indicating an earnings surprise of 18.99% [1] - The company posted revenues of $105.55 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.49%, although this represents a decline from year-ago revenues of $116.18 million [2] - Over the last four quarters, Nevro has exceeded consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Performance - Nevro shares have increased approximately 53.8% since the beginning of the year, contrasting with a decline of -0.5% in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.83 on revenues of $94.92 million, and for the current fiscal year, it is -$2.51 on revenues of $405.98 million [7] Industry Outlook - The Medical - Instruments industry, to which Nevro belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a favorable outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Nevro's stock performance [5]